Evaluating the efficacy of ceftazidime/avibactam plus amikacin combination therapy as a carbapenem-sparing agent against ceftazidime/avibactam-resistant Escherichia coli using a hollow fiber infection model: a proof-of-concept study. (journals.asm.org)

Authors: Walker MM … Sime FB Journal: Antimicrobial Agents and Chemotherapy Published: 2026-06-03 DOI: https://doi.org/10.1128/aac.01377-25